IPO - QT IMAGING HOLDINGS, INC.

Form Type: CORRESP

Filing Date: 2025-02-03

Corporate Action: Ipo

Type: New

Accession Number: 000184450525000019

Filing Summary: QT Imaging Holdings, Inc. has submitted a request to accelerate the effectiveness of its Registration Statement on Form S-1 (File No. 333-284317) under the Securities Act of 1933. The company seeks for the Registration Statement to become effective at 4:00 p.m. Eastern Time on February 5, 2025, or as soon as practicable thereafter. The request is pursuant to Rule 461 of the Securities Act. The company has provided contact information for its counsel, Elena Nrtina, for any questions or concerns regarding this matter.

Document Link: View Document

Form Type: S-1/A

Filing Date: 2025-01-31

Corporate Action: Ipo

Type: Update

Accession Number: 000162828025003316

Filing Summary: QT Imaging Holdings, Inc. has filed an amended registration statement (S-1/A) with the SEC on January 31, 2025, as part of its Initial Public Offering (IPO) process. This filing includes updated financial statements, details on use of proceeds from the offering, risk factors associated with the investment, and corporate governance aspects. The amendment also addresses feedback received from the SEC during the review process and clarifies various aspects of the company's business model, particularly highlighting advancements in medical imaging technology and associated market opportunities. The company aims to enhance its capital structure to support growth and investments in research and development for its ultrasound scanning technologies.

Document Link: View Document

Form Type: S-1

Filing Date: 2025-01-16

Corporate Action: Ipo

Type: New

Accession Number: 000162828025001723

Filing Summary: QT Imaging Holdings, Inc. has filed an S-1 registration statement in preparation for an initial public offering (IPO). This filing includes detailed financial data and a comprehensive overview of its business operations, growth prospects, and market conditions that underline its readiness to enter the public trading environment. The company addresses its strategy to leverage its emerging technologies in the medical imaging sector, particularly focused on developing ultrasound scanners aimed at early cancer detection. Key financial statements and projections are included to bolster investor confidence.

Document Link: View Document